Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium polycarbophil is a synthetic, bulk-forming laxative and antidiarrheal agent. Chemically, it is the calcium salt of polycarbophil, a high-molecular-weight polyacrylic acid cross-linked with divinyl glycol. It functions primarily by absorbing large quantities of water in the gastrointestinal tract, which increases stool bulk and moisture to facilitate bowel movements in cases of constipation, or absorbs excess fluid to improve stool consistency in cases of diarrhea. Beyond its gastrointestinal applications, polycarbophil is utilized as a bioadhesive polymer in non-hormonal vaginal moisturizers (e.g., Replens) to alleviate symptoms of vaginal atrophy and dryness by adhering to the vaginal epithelium and maintaining hydration. It is widely available over-the-counter as a generic and under various brand names.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium polycarbophil.